Dr. Million is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-5055
Summary
- Dr. Lynn Million is a Stanford-based radiation oncologist, with subspecialties including Pediatric Radiation Oncology, Sarcoma, and Skin Cancer. She earned her medical degree from the University of Florida College of Medicine and completed her Radiation Oncology residency at Stanford Health Care. She has extensive experience in treating conditions such as cutaneous t-cell lymphoma, skin cancer, lymphoma, and sarcomas. Dr. Million is presently a Professor at the Stanford University Cancer Center and has previously held positions at the Stanford University School of Medicine and the University of Utah School of Medicine. She is a prolific author in her field, with several publications in Practical Radiation Oncology and Journal of Surgical Oncology, among others. She's been recognized for her work with awards like Career Development Award from ACS, and Research Fellowship Award from ASTRO.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 1987 - 1990
- WellStar Atlanta Medical CenterInternship, Transitional Year, 1986 - 1987
- University of Florida College of MedicineClass of 1986
- Florida State UniversityB.S., 1976 - 1981
Certifications & Licensure
- CA State Medical License 2010 - 2026
- UT State Medical License 1991 - 2012
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Career Development Award ACS, 1993
- Robert R. Newell Award 1991
- Join now to see all
Publications & Presentations
PubMed
- A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer.Michael F Gensheimer, Nikhil V Kotha, Lucas K Vitzthum, Alexander L Chin, Scott Jackson
International Journal of Radiation Oncology, Biology, Physics. 2024-09-25 - Effect of palliative radiation dose on symptom response in metastatic sarcomas.Jennifer K Matsui, Scott Jackson, Judy Fang, Lynn Million, Alexander L Chin
Clinical and Translational Radiation Oncology. 2024-09-01 - 2 citationsEmbryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332.Sheri L Spunt, Wei Xue, Zhengya Gao, Andrea Hayes Dixon, Lynn Million
Cancer. 2024-08-01
Journal Articles
- Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from three...28. Hoppe R, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, Million L, Dabaja B, Duvic M, Gangar, Kim Y, J Am Acad Derm, 1/1/2014
- Successful treatment with temozolomide combined with chemo-radiotherapy and surgery of a metastatic undifferentiated soft tissue sarcoma with relapse in the central ne...Hsu C, Daldrup-Link H, Yeom K, Donaldson S, Million L, Hazard, Rangaswami A, Journal of Adolescent and Young Adult Oncology, 1/1/2014
- Survival and Neurocognitive Outcomes Following Addition of a Cranial or Craniospinal Boost to Total Body Irradiation Prior to Stem Cell Transplantation in Pediatric Le...Hiniker SM, Agarwal R, Modlin LA, Gray CC, Harris JP, Million L, Kiamanesh EF, Donaldson SS, Int J Radiat Oncol Biol Phys, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age: Children's Oncology Group Study ARST0332.Spunt SL, Million L, Anderson JR, Coffin CM, McCarville MB, Randall RL, Parham D, Kao SCS, Hayes-Jordan A, Wolden S, Black J, Laurie F, Tsan E, Speights R, Skapek SX, ..., ASCO, Chicago, IL, 1/1/2014
- Vincristine, dactinomycin, cyclophosphamide (VAC) vs VAC/V+irinotecan (VI) for intermediate risk rhabdomyosarcoma (IRRMS): a report from the Children's Oncology Group ...Hawkins, D, Anderson JR , Mascarenhas L, McCowage G, Rodeberg D, Wolden S, Parham D, Million L, Donaldson S, Hayes-Jordan A, Brown K, Teot L, Spunt S, Meyer W, ASCO, Chicago, IL, 1/1/2014
- Low dose (12 Gy) total skin electron beam therapy (TSEBT) for mycosis fungoides (MF): Results of three phase 2 clinical trials.Hoppe, Harrison C, Tavallaee M, Bashey S, Li S, Million L, Dabaja B, Duvic M, Kim Y, ASTRO, San Francisco, CA, 1/1/2014
- Join now to see all
Lectures
- Low dose (12 Gy) total skin electron beam therapy (TSEBT) for mycosis fungoides (MF): Results of three phase 2 clinical trials.San Francisco, CA - 1/1/2014
- Local control among young patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) following risk-based treatment: results from children's oncology group (COG) s...Berlin - 1/1/2014
- "Onco-diagnosis: Pedatric Soft tissue Sarcoma's"Chicago, IL - 1/1/2013
- Join now to see all
Other
- Pediatric Soft Tissue Sarcoma's: The Role of Radiation Therapy.Smith LM, MD Vista Journal
http://www.mdvista.com
1/1/2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: